Bristol-Myers Squibb (BMY) net assets (shareholders' equity)
Bristol-Myers Squibb (BMY) had net assets of $18.47B at the end of fiscal 2025 (December 31, 2025). That is 13.1% higher than the $16.34B of fiscal 2024. Figures as of 18 Nov 2026, 19:48 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Net assets, fiscal 2025
- $18.47B
- Change on fiscal 2024
- +13.1%
- Growth, 5 years
- −13.4% a year
- Growth, 10 years
- +2.6% a year
- Highest on record
- $51.60Bfiscal 2019
- Lowest on record
- $11.74Bfiscal 2017
- Fiscal years on record
- 182008–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Bristol-Myers Squibb net assets (shareholders' equity), in more detail
Over the five fiscal years to 2025 net assets shrank at a compound 13.4% a year; over ten years the rate was 2.6% a year. Across the 18 fiscal years on record (2008–2025), the highest was $51.60B in fiscal 2019 and the lowest $11.74B in fiscal 2017.
Net assets by fiscal year
Bristol-Myers Squibb net assets (shareholders' equity), year by year
| Fiscal year | Net assets | Change | Year ended |
|---|---|---|---|
| 2025 | $18.47B | 13.1% up | |
| 2024 | $16.34B | 44.5% down | |
| 2023 | $29.43B | 5.3% down | |
| 2022 | $31.06B | 13.6% down | |
| 2021 | $35.95B | 5.0% down | |
| 2020 | $37.82B | 26.7% down | |
| 2019 | $51.60B | 267.7% up | |
| 2018 | $14.03B | 19.5% up | |
| 2017 | $11.74B | 27.4% down | |
| 2016 | $16.18B | 13.4% up | |
| 2015 | $14.27B | 3.9% down | |
| 2014 | $14.85B | 2.0% down | |
| 2013 | $15.15B | 11.2% up | |
| 2012 | $13.62B | 14.6% down | |
| 2011 | $15.96B | 1.5% up | |
| 2010 | $15.71B | 5.9% up | |
| 2009 | $14.84B | 21.3% up | |
| 2008 | $12.24B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.
How to read it
Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.
Net assets at health care companies of similar size
| Company | Net assets | Fiscal year |
|---|---|---|
| Medtronic MDT | $49.46B | 2026 |
| Bristol-Myers Squibb BMY | $18.47B | 2025 |
| Sanofi SNY | €71.38B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Bristol-Myers Squibb, figure by figure
- Bristol-Myers Squibb market cap
- Bristol-Myers Squibb revenue
- Bristol-Myers Squibb earnings
- Bristol-Myers Squibb earnings per share (EPS)
- Bristol-Myers Squibb P/E ratio
- Bristol-Myers Squibb P/S ratio
- Bristol-Myers Squibb P/B ratio
- Bristol-Myers Squibb free cash flow
- Bristol-Myers Squibb operating margin
- Bristol-Myers Squibb dividend
- Bristol-Myers Squibb shares outstanding
- Bristol-Myers Squibb total debt
- Bristol-Myers Squibb cash on hand
- Bristol-Myers Squibb total assets
- Bristol-Myers Squibb total liabilities
- Bristol-Myers Squibb return on equity (ROE)
- Bristol-Myers Squibb return on invested capital (ROIC)
Bristol-Myers Squibb (BMY) overview: price, valuation and scorecardAll health care companies by market value
Bristol-Myers Squibb net assets (shareholders' equity): questions and answers
What are Bristol-Myers Squibb's net assets?
Bristol-Myers Squibb (BMY) had net assets of $18.47B at the end of fiscal 2025 (December 31, 2025). That is 13.1% higher than the $16.34B of fiscal 2024.
What is the growth rate of Bristol-Myers Squibb's net assets?
Over the five fiscal years to 2025 net assets shrank at a compound 13.4% a year; over ten years the rate was 2.6% a year.
What are the highest and lowest net assets figures on record for Bristol-Myers Squibb?
Across the 18 fiscal years on record (2008–2025), the highest was $51.60B in fiscal 2019 and the lowest $11.74B in fiscal 2017.
How is Bristol-Myers Squibb's net assets calculated?
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Bristol-Myers Squibb it is on record here for 18 fiscal years, 2008 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: net assets (shareholders' equity)
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Bristol-Myers Squibb (BMY) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/net-assets
Underlying data: the company's filings with the SEC and Yahoo Finance.